Delaware State Employees Face Higher GLP-1 Drug Co-Pays
Dover News Today | 2 Min News | The Daily News Now! · The Daily News Now!
Audio is streamed directly from the publisher (api.fastcast.ai) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Delaware state employees and retirees face a significant increase in co-pays for GLP-1 drugs used in weight loss, rising from $32 to $200 per month starting July 1st. The State Employee Benefits Committee voted 6-5 to keep coverage despite rising drug prices and drug makers lack of commitment to cost assistance. Opponents argue the new co-pay is unfair, especially for lower-wage workers. The committee also approved a 2.2% premium hike for the main health plan, affecting over 135,000 people. These measures aim to control escalating medical expenses amid annual rises of 4-8%.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
[email protected]
This is an automated, high-level news summary based on public reporting.
Report issues to [email protected].
View sources & latest updates:
https://sources.thednn.ai/c6cfeba22fea3523